Perrigo Company plc (NYSE: PRGO), an Ireland-based global provider of Consumer Self-Care Products, announced on Wednesday that its board of directors has declared a quarterly dividend of USD0.290 per share, payable on September 16, 2025, to shareholders of record on August 29, 2025. This amount is unchanged from the previous quarterly dividend.
Perrigo Company plc is a pure-play self-care company with over a century of experience in providing health and wellness solutions to consumers, primarily in North America and Europe.
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
Perrigo to divest Dermacosmetics business for up to EUR327m
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea
Sanofi to acquire Blueprint Medicines in USD9.5bn rare disease deal
Eisai forecasts 73% Leqembi revenue growth in FY 2025, boosting BioArctic royalties